Comparison

SB408124 European Partner

Item no. S1545-25
Manufacturer Selleckchem
CASRN 288150-92-5
Amount 25 mg
Quantity options 10 mg 100 mg 1 g 10 g 10 mM/1 ml 25 mg 5 mg 5 g
Category
Type Inhibitors
Specific against other
Smiles CC1=CC(=C2C=C(C=C(C2=N1)F)F)NC(=O)NC3=CC=C(C=C3)N(C)C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias OX1 (whole cell),OX1 (membrane),Others
Similar products SB-408124
Available
Storage Conditions
2 years -80 in solvent
Molecular Weight
356, 37
Administration
Intracerebroventricularly (i.c.v.) injected into the lateral ventricle of the rat.
Animal Models
Male Wistar rats
Dosages
30 ug/10 uL
Formulation
SB-408124 is dissolved in saline.
IC50
57 nM (Ki), 57 nM (Ki), 57 nM (Ki), 57 nM (Ki), 57 nM (Ki), 57 nM (Ki)
In vitro
SB-408124 binds hypocretin type 1 receptor (HcrtR1) with pKi values of 7.57. Calcium mobilization studies shows that SB-408124 is a functional antagonist of the OX1 receptor with a affinity of approximately 50-fold selectivity over the OX2 receptor. [1] A recent study indicates that pretreatment of primary cultures of rat astrocytes with SB-401824 before Orexin A administration significantly reduced the stimulatory action of Orexin A on both basal and forskolin-acivated cAMP production. [2]
In vivo
SB-408124 (30 ug/10 uL, administered intracerebroventricularly) decreases Orexin-A induced water intake in Wistar rats. Intracerebroventricularly administered Orexin-A (30 ug/10 uL) blocks the vasopressin (VP) level increase induced by either histamine or 2.5% NaCl administration, and this blocking effect is moderated by pretreatment with SB-408124. [3], Intracerebroventricular pretreatment with SB-408124 (50 mM, 5 uL/h) prevents Bicuculline (BIC)-induced increases in endogenous glucose production (EGP). [4]
Kinase Assay
Whole cell binding assays, After overnight culture in 96-well Packard Cultur plates, the medium is discarded and cells are incubated in buffer containing 150 mM NaCl, 20 mM HEPES and 0.5% bovine serum albumin (pH 7.4) for 60 minutes at 25 C. Saturation studies are carried out by incubating cells with a range of concentrations of [3H]SB-408124 (0.2–24 nM), the total assay volume is 250 uL. Protein content is assayed by lysing cells with 0.1M NaOH and using the Bradford method with bovine serum albumin (BSA) as a standard. Association kinetic studies are performed by measuring the specific binding of [3H]SB-408124 (3 nM) at 1–60 minutes after addition of [3H]SB-408124. All assays are terminated by washing the cells three times with 250uL ice-cold phosphate-buffered saline. A volume of 100 uL of Microscint 40 is added to each well and the plate is left at room temperature for 2 hours. Cell-associated radioactivity is then measured using a Packard Topcount, with a count time of 2 minute/well.
Solubility (25C)
DMSO 36 mg/mL, Water <1 mg/mL, Ethanol <1 mg/mL
Information
SB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor.
Chemical Name
1-(6, 8-difluoro-2-methylquinolin-4-yl)-3-(4-(dimethylamino)phenyl)urea

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?